NCT06703229View on ClinicalTrials.gov

Assessment of the Impact of Two Dexmedetomidine Dosages Added with Bupivacaine in Ultrasound-Guided Transversus Abdominis Plane Block for Postoperative Analgesia Following Inguinal Hernia Repair

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

November 15, 2024

Study Completion Date

November 15, 2024

Conditions
Spinal AnaesthesiaHerniorrhaphyTransversus Abdominis Plane Block
Interventions
DRUG

The Transversus Abdominis Plane (TAP) block

or injectate preparation, utilizing ultrasound guidance while the patient was supine. In the D1 group, patients were administered 20 mL of 0.25% isobaric bupivacaine with 0.5 mcg/kg of dexmedetomidine.

DRUG

The transverse abdominis plane (TAP) block

Patients in the D2 group received 20 mL of 0.25% isobaric bupivacaine with 1 mcg/kg of dexmedetomidine.

Trial Locations (1)

42526

Egyptian liver hospital, Al Mansurah

All Listed Sponsors
lead

Helwan University

OTHER

NCT06703229 - Assessment of the Impact of Two Dexmedetomidine Dosages Added with Bupivacaine in Ultrasound-Guided Transversus Abdominis Plane Block for Postoperative Analgesia Following Inguinal Hernia Repair | Biotech Hunter | Biotech Hunter